Corinna Dannecker

Low-Density Lipoprotein Cholesterol Is Associated With Insulin Secretion

N. Stefan, M. Heni, A. Fritsche, 2021, The Journal of clinical endocrinology and metabolism.

Empagliflozin Improves Insulin Sensitivity of the Hypothalamus in Humans With Prediabetes: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial.

R. Veit, H. Preissl, J. Machann, 2021, Diabetes care.

Different Effects of Lifestyle Intervention in High- and Low-Risk Prediabetes: Results of the Randomized Controlled Prediabetes Lifestyle Intervention Study (PLIS)

F. Schick, M. Stumvoll, N. Stefan, 2021, Diabetes.

Eight weeks of empagliflozin does not affect pancreatic fat content and insulin secretion in people with prediabetes

J. Machann, S. Kullmann, M. Heni, 2022, Diabetes, obesity & metabolism.

Diabetes and the Prostate: Elevated Fasting Glucose, Insulin Resistance and Higher Levels of Adrenal Steroids in Prostate Cancer

M. Heni, A. Fritsche, H. Häring, 2022, Journal of clinical medicine.

The TUDID Study - Background and Design of a Prospective Cohort.

N. Stefan, G. Willmann, N. Heyne, 2020, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

Risk-stratified lifestyle intervention to prevent type 2 diabetes

F. Schick, M. Stumvoll, N. Stefan, 2021, medRxiv.

Free fatty acids, glicentin and glucose-dependent insulinotropic polypeptide as potential major determinants of fasting substrate oxidation

N. Stefan, J. Machann, M. Heni, 2021, Scientific Reports.

Network-targeted transcranial direct current stimulation of the hypothalamus appetite-control network: a feasibility study

H. Preissl, S. Kullmann, M. Heni, 2024, Scientific reports.

Mechanisms of weight loss-induced remission in people with prediabetes: a post-hoc analysis of the randomised, controlled, multicentre Prediabetes Lifestyle Intervention Study (PLIS).

H. Preissl, V. Ntziachristos, J. Machann, 2023, The lancet. Diabetes & endocrinology.